Expression of high-mobility group box 1 and of receptor for advanced glycation end products in chronic obstructive pulmonary disease (Q39743331)

14 September 2017

Expression of high-mobility group box 1 and of receptor for advanced glycation end products in chronic obstructive pulmonary disease (English)

1 reference

chronic obstructive pulmonary disease

14 September 2017

0 references

author name string

Nassima Ferhani

1

1 reference

14 September 2017

Séverine Letuve

2

1 reference

14 September 2017

Alexander Kozhich

3

1 reference

14 September 2017

Olivier Thibaudeau

4

1 reference

14 September 2017

Martine Grandsaigne

5

1 reference

14 September 2017

Marielle Maret

6

1 reference

14 September 2017

Marie-Christine Dombret

7

1 reference

14 September 2017

Gary P Sims

8

1 reference

14 September 2017

Roland Kolbeck

9

1 reference

14 September 2017

Anthony J Coyle

10

1 reference

14 September 2017

Michel Aubier

11

1 reference

14 September 2017

Marina Pretolani

12

1 reference

14 September 2017

language of work or name

English

0 references

publication date

4 February 2010

1 reference

American Journal of Respiratory and Critical Care Medicine

14 September 2017

1 reference

14 September 2017

181

1 reference

14 September 2017

9

1 reference

14 September 2017

917-927

1 reference

Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease

14 September 2017

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200903-0340OC

New concepts in the pathobiology of chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200903-0340OC

Pathophysiology of airflow limitation in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200903-0340OC

High-mobility group box 1 (HMGB1) protein: friend and foe.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200903-0340OC

The cytokine activity of HMGB1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200903-0340OC

Pivotal advances: high-mobility group box 1 protein--a cytokine with a role in cardiac repair

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200903-0340OC

Increased expression of the DNA-binding cytokine HMGB1 in human atherosclerotic lesions: role of activated macrophages and cytokines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200903-0340OC

HMGB1 contributes to the development of acute lung injury after hemorrhage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200903-0340OC

Potential role of high-mobility group box 1 in cystic fibrosis airway disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200903-0340OC

The role of high mobility group box1 in pulmonary fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200903-0340OC

The high mobility group (HMG) boxes of the nuclear protein HMG1 induce chemotaxis and cytoskeleton reorganization in rat smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200903-0340OC

High mobility group box 1 protein binding to lipopolysaccharide facilitates transfer of lipopolysaccharide to CD14 and enhances lipopolysaccharide-mediated TNF-alpha production in human monocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200903-0340OC

HMGB1 develops enhanced proinflammatory activity by binding to cytokines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200903-0340OC

The alarmin HMGB1 acts in synergy with endogenous and exogenous danger signals to promote inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200903-0340OC

Toll-like receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200903-0340OC

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200903-0340OC

Understanding RAGE, the receptor for advanced glycation end products

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200903-0340OC

Extracellular HMGB1, a signal of tissue damage, induces mesoangioblast migration and proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200903-0340OC

Advanced glycation end products induce tubular epithelial-myofibroblast transition through the RAGE-ERK1/2 MAP kinase signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200903-0340OC

Airway structural alterations selectively associated with severe asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200903-0340OC

Altered Nrf2/Keap1-Bach1 equilibrium in pulmonary emphysema

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200903-0340OC

Mediators of chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200903-0340OC

The nuclear protein HMGB1 is secreted by monocytes via a non-classical, vesicle-mediated secretory pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200903-0340OC

The balance between IL-1 and IL-1Ra in disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200903-0340OC

IL-1alpha and IL-1beta are endogenous mediators linking cell injury to the adaptive alloimmune response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200903-0340OC

Increased number of B-cells in bronchial biopsies in COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200903-0340OC

HMGB1 B box increases the permeability of Caco-2 enterocytic monolayers and impairs intestinal barrier function in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200903-0340OC

Airway epithelial repair, regeneration, and remodeling after injury in chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200903-0340OC

HMGB1-stimulated human primary cardiac fibroblasts exert a paracrine action on human and murine cardiac stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200903-0340OC

Legionella pneumophila infection induces programmed cell death, caspase activation, and release of high-mobility group box 1 protein in A549 alveolar epithelial cells: inhibition by methyl prednisolone

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200903-0340OC

Receptor for advanced glycation end-products is a marker of type I cell injury in acute lung injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200903-0340OC

Amplification of inflammation in emphysema and its association with latent adenoviral infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200903-0340OC

Smoking-dependent reprogramming of alveolar macrophage polarization: implication for pathogenesis of chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200903-0340OC

RAGE: developmental expression and positive feedback regulation by Egr-1 during cigarette smoke exposure in pulmonary epithelial cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200903-0340OC

Activation of tubular epithelial cells in diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200903-0340OC

The receptor for advanced glycation end products is highly expressed in the skin and upregulated by advanced glycation end products and tumor necrosis factor-alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200903-0340OC

Central role of RAGE-dependent neointimal expansion in arterial restenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200903-0340OC

RAGE: a single receptor for several ligands and different cellular responses: the case of certain S100 proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200903-0340OC

S100A4: a common mediator of epithelial-mesenchymal transition, fibrosis and regeneration in diseases?

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200903-0340OC

Different expression ratio of S100A8/A9 and S100A12 in acute and chronic lung diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200903-0340OC

Imbalances between interleukin-1 and tumor necrosis factor agonists and antagonists in stable COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200903-0340OC

Squamous metaplasia amplifies pathologic epithelial-mesenchymal interactions in COPD patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200903-0340OC

Interleukin-1beta causes pulmonary inflammation, emphysema, and airway remodeling in the adult murine lung.

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200903-0340OC

Increased expression of the novel proinflammatory cytokine high mobility group box chromosomal protein 1 in skin lesions of patients with lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1164%2FRCCM.200903-0340OC

10.1164/RCCM.200903-0340OC

21 January 2018

Identifiers

DOI

1 reference

14 September 2017

1 reference